Sort by:
Need a comprehensive medical report on "A"?
Analyze the latest clinical research and treatment options
Summarize scientific findings from medical journals
A Study of HDM2012 in Patients With Advanced Solid Tumor
Not Applicable
Recruiting
- Conditions
- Advanced Solid Tumors
- Interventions
- Drug: HDM2012
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-05
- Target Recruit Count
- 129
- Registration Number
- NCT07100249
- Locations
- 🇨🇳
Zhongshan Hospital, Fudan University, Shanghai, China
A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects
Not Applicable
Not yet recruiting
- Conditions
- Non - Alcoholic Steatohepatitis
- Interventions
- Drug: HEC169584 capsuleDrug: placebo
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT07099118
- Locations
- 🇨🇳
No. 49, Huayuan North Road, Haidian District, Beijing Municipality, Beijing, Beijing, China
A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetic Profile of Single and Multiple Dose Escalation Topical Dermal Administration of SHR0302 Alkali Gel in Healthy Subjects
Not Applicable
Completed
- Conditions
- Preoperative Sedation of Adults
- Interventions
- Drug: SHR0302 Base Gel Placebo
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT07098117
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
The Use of Nasogastric Tubes and Water-Soluble Contrast With or Without Radiographic Imaging in The Management of Adhesive Small Bowel Obstruction: A Feasibility Study
Not Applicable
Not yet recruiting
- Conditions
- Small Bowel Obstruction
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 60
- Registration Number
- NCT07099300
The Effect of a Self-Compassionate Mindfulness Psychoeducation Program Implemented in Prison on Internalized Stigma, Emotion Regulation, and Forgiveness in Juvenile Delinquents
Not Applicable
Not yet recruiting
- Conditions
- Juvenile Delinquency
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Ondokuz Mayıs University
- Target Recruit Count
- 68
- Registration Number
- NCT07098637
A New Tool for Extubation Readiness in Mechanically Ventilated Patients: Readiness for EXtubation Score
Recruiting
- Conditions
- Ventilator WeaningRespiration, ArtificialRespiratory FailureExtubation SucceededExtubation ReadinessExtubation FailureIntensive Care Patients Invasively VentilatedWeaning Invasive Mechanical Ventilation
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Medipol University
- Target Recruit Count
- 470
- Registration Number
- NCT07098611
- Locations
- 🇨🇱
University of Magallanes, Punta Arenas, Chile
🇪🇬Cairo University, Cairo, Egypt
🇮🇷Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
Not Applicable
Not yet recruiting
- Conditions
- Neoplasms, Lung
- Interventions
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 300
- Registration Number
- NCT07099898
A Study Of Cryptoglandular Fistula-in-ano And Associated Non-healing Draining Wounds With Kerecis SurgiClose
Not Applicable
Not yet recruiting
- Conditions
- Fistula-in-anoDraining Wound
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT07098715
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder: A Pilot Study
Not Applicable
Not yet recruiting
- Conditions
- Infusion of Ketamine in Severe Borderline Personality DisorderBorderline Personality Disorder (BPD)
- Interventions
- Drug: IV Ketamine (0.5 mg/kg) Infusion - Two Doses Administered 24 Hours Apart for Severe Borderline Personality Disorder
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 38
- Registration Number
- NCT07099534
- Locations
- 🇫🇷
Toulouse Purpan University Hospital, Head of Psychiatry Clinic in the UF3 department, Toulouse, France
Microbiota in Children With Severe Burn Injury
Not Applicable
Active, not recruiting
- Conditions
- Burn
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Target Recruit Count
- 40
- Registration Number
- NCT07098377
- Locations
- 🇮🇹
Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy